Research Article
Interplay between Nox2 Activity and Platelet Activation in Patients with Sepsis and Septic Shock: A Prospective Study
Table 1
Clinical characteristics of all patients and comparison between patients with sepsis and those with septic shock.
| | Variables | Healthy controls () | Overall () | Patients with sepsis () | Patients with septic shock () | |
| | Demographics | | | | | | | Male | 5 (50%) | 16 (48.5%) | 9 (45%) | 7 (53.8%) | 0.619 | | Age, median (IQR) | 68.5 (62-73) | 75 (54-85) | 74 (54-82.5) | 79 (52.5-86.5) | 0.888 | | Previous hospitalization, last 3 months | — | 14 (42.4%) | 7 (35%) | 7 (53.8%) | 0.284 | | Previous antibiotic therapy, last 30 days | — | 7 (21.1%) | 6 (30%) | 1 (7.7%) | 0.126 | | Comorbidities | | | | | | | Cardiovascular disease | — | 19 (57.6%) | 11 (55%) | 8 (61.5%) | 0.710 | | Chronic heart failure | — | 9 (27.3%) | 4 (20%) | 5 (38.5%) | 0.245 | | Diabetes | — | 7 (21.1%) | 5 (25%) | 2 (15.4%) | 0.509 | | Chronic kidney disease | — | 15 (45.5%) | 7 (30%) | 8 (61.5%) | 0.073 | | Hepatic disease | — | 4 (12.1%) | 1 (5%) | 3 (23.1%) | 0.120 | | Neurologic disease | — | 8 (24.2%) | 5 (25%) | 3 (23.1%) | 0.9 | | COPD | — | 9 (27.3%) | 6 (20%) | 3 (23.1%) | 0.833 | | Solid cancer | — | 7 (21.1%) | 5 (25%) | 2 (15.4%) | 0.509 | | Splenectomy | — | 1 (3%) | 0 | 1 (7.7%) | 0.208 | | Aspirin use | — | 10 (30.3%) | 7 (35%) | 3 (23.1%) | 0.466 | | Charlson Comorbidity Index | — | | 4.5 (1-7) | 8 (2-9) | 0.298 | | Source of infection | | | | | | | Respiratory tract | — | 9 (27.3%) | 6 (30%) | 3 (23.1%) | 0.663 | | Genitourinary tract | — | 8 (24.2%) | 4 (20%) | 4 (30.8%) | 0.481 | | Abdomen | — | 8 (24.2%) | 4 (20%) | 4 (30.8%) | 0.481 | | Skin and soft tissue | — | 1 (3%) | 1 (5%) | 0 | 0.413 | | Meningitis | — | 1 (3%) | 1 (5%) | 0 | 0.413 | | Bone | — | 1 (3%) | 1 (5%) | 0 | 0.413 | | Intravascular device | — | 1 (3%) | 0 | 1 (7.7%) | 0.208 | | Others | — | 4 (12.1%) | 3 (15%) | 1 (7.7%) | 0.530 | | PICC | — | 3 (9.1%) | 2 (10%) | 1 (7.7%) | 0.822 | | CVC | — | 2 (6.1%) | 1 (5%) | 1 (7.7%) | 0.751 | | NIV | — | 4 (12.1%) | 2 (10%) | 2 (15.4%) | 0.643 | | Severity scores of sepsis | | | | | | | SAPS-II | — | 34 (23.5-42) | 32 (17.5-38) | 37 (31-51) | 0.024 | | qSOFA | — | 2 (1-2) | 1 (0-2) | 2 (2-2.5) | 0.002 | | SOFA score | — | 6 (4-10) | 4.5 (2-6) | 10 (7.5-12) | <0.001 | | Use of inotropes | — | 9 (27.3%) | — | 9 (69.2%) | <0.001 | | Mortality | — | 9 (27.3%) | 3 (15%) | 6 (46.2%) | 0.050 |
|
|
COPD = chronic obstructive pulmonary disease; CVC = central venous catheter; IQR: interquartile range; NIV = noninvasive ventilation; PICC = peripheral inserted central catheter. Others include 1 malaria (sepsis), 1 mononucleosis (sepsis), and 2 bacteremia with an unknown source of infection (1 sepsis and 1 septic shock). |